SECTION 1: Referral Evaluation and Listing
CHAPTER 1: General Referral and Listing Criteria
CHAPTER 2: Disease Specific Issues Regarding Lung Transplantation
- Part A: Cystic Fibrosis
Part B: Pulmonary Hypertension - Part C: Sufactant Protein Abnormalities/chILD
CHAPTER 3: Timing of Listing and Patient Management on the Waiting List
SECTION II: Peri-transplant Management
CHAPTER 4: Pediatric Aspects of Lung Transplant Surgery - Including Historic Perspective
CHAPTER 5: Pediatric Issues of Donor Selection
CHAPTER 6: Early Post-operative Issues in the Intensive Care
Unit
- Part A: Primary Graft Failure
- Part B: Pediatric ECMO Support
CHAPTER 7: Immunosuppression Induction & Maintenance Therapy
SECTION III: Post-transplant Complications and Co-morbidities
CHAPTER 8: Infectious Diseases Issues
CHAPTER 9: Monitoring for and Treatment of Acute Allograft Rejection
CHAPTER 10: Diagnosis and Management of Antibody-Mediated Rejection
Following Pediatric Lung Transplantation
CHAPTER 11: Monitoring and Treatment of Bronchiolitis Obliterans Syndrome
CHAPTER 12: Gastroesophageal Reflux Disease
CHAPTER 13: Post-transplant Co-morbidities
- Part A: Chronic Kidney Disease
- Part B: Diabetes
- Part C: Bone Health
CHAPTER 14: PTLD and Cancer
SECTION IV: Outcomes
CHAPTER 15: Survival and Functional Status
CHAPTER 16: Special Populations
- Part A: Living Donor Lung Transplantation
- Part B: Infant Lung Transplantation
- Part C: Multi-organ Transplantation
- Part D: Re-transplantation
CHAPTER 17: Psychosocial Outcomes: Growth and Development
CHAPTER 18: Impact of Developmental
Immunology on Outcomes
SECTION V: Psychosocial Aspects
CHAPTER 19: Care Transitions
- Part A: Transition to Local Care and Scheduled Follow-up
- Part B: Transition from Pediatric to Adult Services
CHAPTER 20: End of Life Care
- Part A: Pre-transplant
- Part B: Post-transplant
SECTION VI: The Future
CHAPTER 21: Future of Pediatric Lung Transplantation
